Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A new species of <i>Atriophallophorus</i> Deblock & Rosé, 1964 (Trematoda: Microphallidae) described from <i>in vitro</i>-grown adults and metacercariae from <i>Potamopyrgus antipodarum</i> (Gray, 1843) (Mollusca: Tateidae).

Journal of helminthology·2019
Same author

Comparison of Gastric Histology Among Swedish and Japanese Patients with Peptic Ulcer and &lt;emph type="2"&gt;Helicobacter pylori&lt;/emph&gt; Infection.

Scandinavian journal of gastroenterology·2017
Same author

Comparing direct and indirect selfing rate estimates: when are population-structure estimates reliable?

Heredity·2017
Same author

OLGA staging for gastritis: a tutorial.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2008
Same author

Beneficial effect of resin salve in treatment of severe pressure ulcers: a prospective, randomized and controlled multicentre trial.

The British journal of dermatology·2008
Same author

Oligonucleotide array comparative genomic hybridization refines the structure of 8p23.1, 17q12 and 20q13.2 amplifications in gastric carcinomas.

Cytogenetic and genome research·2007

相关实验视频

Updated: Jun 24, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

在根除了Helicobacter pylori之后,IgG,IgA和IgM抗体标位下降的诊断值.

T U Kosunen1, K Seppälä, S Sarna

  • 1Department of Bacteriology and Immunology, University of Helsinki, Finland.

Lancet (London, England)
|April 11, 1992
PubMed
概括

对Helicobacter pylori的抗体标位可靠地表明了根除. 在治疗后六个月内显著降低IgG抗体标位,证实了H. pylori根除的成功.

科学领域:

  • 免疫学 免疫学 免疫学
  • 胃肠病学 胃肠病学
  • 微生物学 微生物学

背景情况:

  • 在成功根除后,Helicobacter pylori的抗体标位下降.
  • 需要可靠的指标来确认H. pylori的根除.

研究的目的:

  • 为了确定抗体标位下降的程度,表明H. pylori根除.
  • 评估不同类型的免疫球蛋白 (IgG,IgA,IgM) 对监测根除成功的有用性.

主要方法:

  • 144名患有H. pylori感染的患者接受了抗菌疗法.
  • 随访包括血清学测试,细菌培养和组织学在6周,6个月和12个月.
  • 与根除状态相关的IgG,IgA和IgM抗体标位的变化被分析.

主要成果:

  • 在6周后,IgG标位下降了20-30%,不论根除是否成功.
  • 在根除的患者中 (n=121),在6-12个月后IgG标位≤50%的基线 (97%的灵敏度).
  • 在持久性感染 (n=23) 中,IgG标位在初始下降后保持稳定或增加.

结论:

  • 一致的IgG抗体标位在6个月内降至≤50%,可靠地表明了H. pylori的根除.

更多相关视频

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

相关实验视频

Last Updated: Jun 24, 2026

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology
05:13

Rapid Detection of Helicobacter pylori Virulence and Typing Using Quantum Dot Labeling Technology

Published on: June 13, 2025

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

  • IgG抗体测试具有高度灵敏度,对于监测抗菌疗法的成功非常有用.
  • 血清学测试提供了一种具有成本效益和可靠的方法来评估H. pylori根除.